Targeting Enzymes for Pharmaceutical Development: Methods and Protocols
This volume explores detailed methods and experimental protocols evaluating the effect of a compound or a mixture of compounds on the action of enzymes that are significant targets in pharmaceuticals. Consisting of three sections, the book delves into recent biocomputing and bioinformatics protocols...
Gespeichert in:
Format: | Elektronisch E-Book |
---|---|
Sprache: | English |
Veröffentlicht: |
New York, NY
Springer US
2020
|
Ausgabe: | 1st ed. 2020 |
Schriftenreihe: | Methods in Molecular Biology
2089 |
Schlagworte: | |
Online-Zugang: | UBR01 TUM01 Volltext |
Zusammenfassung: | This volume explores detailed methods and experimental protocols evaluating the effect of a compound or a mixture of compounds on the action of enzymes that are significant targets in pharmaceuticals. Consisting of three sections, the book delves into recent biocomputing and bioinformatics protocols, state-of-the art modern biophysical, electrophoretic, and chromatographic methods and high-throughput screening approaches, as well as detailed protocols and examples of the inhibition analysis and evaluation of selected enzymes. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, Targeting Enzymes for Pharmaceutical Development: Methods and Protocols serves as a vital reference for academics and industry professionals working on expanding our understanding of the wide range of important enzyme targets. The chapter "Enzyme-Ligand Interaction Monitored by Synchrotron Radiation Circular Dichroism" is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com |
Beschreibung: | In Silico Laboratory: Tools for Similarity-Based Drug Discovery -- The In Silico Fischer Lock-and-Key Model: The Combined Use of Molecular Descriptors and Docking Poses for the Repurposing of Old Drugs -- Determination of Half-Maximal Inhibitory Concentration of an Enzyme Inhibitor -- Applications of Differential Scanning Fluorometry and Related Technologies in Characterization of Protein-Ligand Interactions -- High-Throughput Differential Scanning Fluorimetry of GFP-Tagged Proteins -- Enzyme-Ligand Interaction Monitored by Synchrotron Radiation Circular Dichroism -- Measuring Small Molecule Binding to Escherichia coli AcrB by Surface Plasmon Resonance -- Systematic Screening of Viral Entry Inhibitors Using Surface Plasmon Resonance -- Screening of Beta-Secretase Inhibitors by Capillary Electrophoresis-Mass Spectrometry -- Electrophoretic Mobility Shift Assays with GFP-Tagged Proteins (GFP-EMSA) -- On-Line Enantioselective Capillary Electrophoretic Method for Screening Cytochrome P450 3A4 Inhibitors -- Enzymatic Bioautographic Methods -- High-Throughput Assessment of Metabolism-Induced Toxicity of Compounds on a 384-Pillar Plate -- Droplet-Based Microfluidics Methods for Detecting Enzyme Inhibitors -- Ligand Fishing: An Approach for the Discovery Inhibitors from Complex Biological Mixtures -- HMG-CoA Reductase as Target for Drug Development -- Lipoxygenases as Targets for Drug Development -- Cholinesterase as a Target for Drug Development in Alzheimer's Disease |
Beschreibung: | 1 Online-Ressource (XI, 290 Seiten) Illustrationen |
ISBN: | 9781071601631 |
DOI: | 10.1007/978-1-0716-0163-1 |
Internformat
MARC
LEADER | 00000nmm a2200000zcb4500 | ||
---|---|---|---|
001 | BV047606951 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 211123s2020 |||| o||u| ||||||eng d | ||
020 | |a 9781071601631 |9 978-1-07-160163-1 | ||
024 | 7 | |a 10.1007/978-1-0716-0163-1 |2 doi | |
035 | |a (ZDB-2-PRO)978-1-0716-0163-1 | ||
035 | |a (OCoLC)1286867725 | ||
035 | |a (DE-599)BVBBV047606951 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-355 |a DE-91 | ||
082 | 0 | |a 615.19 | |
245 | 1 | 0 | |a Targeting Enzymes for Pharmaceutical Development |b Methods and Protocols |c edited by Nikolaos E. Labrou |
250 | |a 1st ed. 2020 | ||
264 | 1 | |a New York, NY |b Springer US |c 2020 | |
300 | |a 1 Online-Ressource (XI, 290 Seiten) |b Illustrationen | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Methods in Molecular Biology |v 2089 | |
500 | |a In Silico Laboratory: Tools for Similarity-Based Drug Discovery -- The In Silico Fischer Lock-and-Key Model: The Combined Use of Molecular Descriptors and Docking Poses for the Repurposing of Old Drugs -- Determination of Half-Maximal Inhibitory Concentration of an Enzyme Inhibitor -- Applications of Differential Scanning Fluorometry and Related Technologies in Characterization of Protein-Ligand Interactions -- High-Throughput Differential Scanning Fluorimetry of GFP-Tagged Proteins -- Enzyme-Ligand Interaction Monitored by Synchrotron Radiation Circular Dichroism -- Measuring Small Molecule Binding to Escherichia coli AcrB by Surface Plasmon Resonance -- Systematic Screening of Viral Entry Inhibitors Using Surface Plasmon Resonance -- Screening of Beta-Secretase Inhibitors by Capillary Electrophoresis-Mass Spectrometry -- Electrophoretic Mobility Shift Assays with GFP-Tagged Proteins (GFP-EMSA) -- On-Line Enantioselective Capillary Electrophoretic Method for Screening Cytochrome P450 3A4 Inhibitors -- Enzymatic Bioautographic Methods -- High-Throughput Assessment of Metabolism-Induced Toxicity of Compounds on a 384-Pillar Plate -- Droplet-Based Microfluidics Methods for Detecting Enzyme Inhibitors -- Ligand Fishing: An Approach for the Discovery Inhibitors from Complex Biological Mixtures -- HMG-CoA Reductase as Target for Drug Development -- Lipoxygenases as Targets for Drug Development -- Cholinesterase as a Target for Drug Development in Alzheimer's Disease | ||
520 | |a This volume explores detailed methods and experimental protocols evaluating the effect of a compound or a mixture of compounds on the action of enzymes that are significant targets in pharmaceuticals. Consisting of three sections, the book delves into recent biocomputing and bioinformatics protocols, state-of-the art modern biophysical, electrophoretic, and chromatographic methods and high-throughput screening approaches, as well as detailed protocols and examples of the inhibition analysis and evaluation of selected enzymes. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, Targeting Enzymes for Pharmaceutical Development: Methods and Protocols serves as a vital reference for academics and industry professionals working on expanding our understanding of the wide range of important enzyme targets. The chapter "Enzyme-Ligand Interaction Monitored by Synchrotron Radiation Circular Dichroism" is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com | ||
650 | 4 | |a Pharmaceutical technology | |
650 | 4 | |a Enzymology | |
650 | 4 | |a Medicinal chemistry | |
700 | 1 | |a Labrou, Nikolaos |e Sonstige |0 (DE-588)1196634866 |4 oth | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781071601624 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781071601648 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781071601655 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-1-0716-0163-1 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-PRO | ||
940 | 1 | |q ZDB-2-PRO_2020_Fremddaten | |
999 | |a oai:aleph.bib-bvb.de:BVB01-032991935 | ||
966 | e | |u https://doi.org/10.1007/978-1-0716-0163-1 |l UBR01 |p ZDB-2-PRO |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1007/978-1-0716-0163-1 |l TUM01 |p ZDB-2-PRO |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804182971600601088 |
---|---|
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author_GND | (DE-588)1196634866 |
building | Verbundindex |
bvnumber | BV047606951 |
collection | ZDB-2-PRO |
ctrlnum | (ZDB-2-PRO)978-1-0716-0163-1 (OCoLC)1286867725 (DE-599)BVBBV047606951 |
dewey-full | 615.19 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615.19 |
dewey-search | 615.19 |
dewey-sort | 3615.19 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
discipline_str_mv | Medizin |
doi_str_mv | 10.1007/978-1-0716-0163-1 |
edition | 1st ed. 2020 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04491nmm a2200469zcb4500</leader><controlfield tag="001">BV047606951</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">211123s2020 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781071601631</subfield><subfield code="9">978-1-07-160163-1</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-0716-0163-1</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-PRO)978-1-0716-0163-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1286867725</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047606951</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-91</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Targeting Enzymes for Pharmaceutical Development</subfield><subfield code="b">Methods and Protocols</subfield><subfield code="c">edited by Nikolaos E. Labrou</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed. 2020</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY</subfield><subfield code="b">Springer US</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XI, 290 Seiten)</subfield><subfield code="b">Illustrationen</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Methods in Molecular Biology</subfield><subfield code="v">2089</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">In Silico Laboratory: Tools for Similarity-Based Drug Discovery -- The In Silico Fischer Lock-and-Key Model: The Combined Use of Molecular Descriptors and Docking Poses for the Repurposing of Old Drugs -- Determination of Half-Maximal Inhibitory Concentration of an Enzyme Inhibitor -- Applications of Differential Scanning Fluorometry and Related Technologies in Characterization of Protein-Ligand Interactions -- High-Throughput Differential Scanning Fluorimetry of GFP-Tagged Proteins -- Enzyme-Ligand Interaction Monitored by Synchrotron Radiation Circular Dichroism -- Measuring Small Molecule Binding to Escherichia coli AcrB by Surface Plasmon Resonance -- Systematic Screening of Viral Entry Inhibitors Using Surface Plasmon Resonance -- Screening of Beta-Secretase Inhibitors by Capillary Electrophoresis-Mass Spectrometry -- Electrophoretic Mobility Shift Assays with GFP-Tagged Proteins (GFP-EMSA) -- On-Line Enantioselective Capillary Electrophoretic Method for Screening Cytochrome P450 3A4 Inhibitors -- Enzymatic Bioautographic Methods -- High-Throughput Assessment of Metabolism-Induced Toxicity of Compounds on a 384-Pillar Plate -- Droplet-Based Microfluidics Methods for Detecting Enzyme Inhibitors -- Ligand Fishing: An Approach for the Discovery Inhibitors from Complex Biological Mixtures -- HMG-CoA Reductase as Target for Drug Development -- Lipoxygenases as Targets for Drug Development -- Cholinesterase as a Target for Drug Development in Alzheimer's Disease</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This volume explores detailed methods and experimental protocols evaluating the effect of a compound or a mixture of compounds on the action of enzymes that are significant targets in pharmaceuticals. Consisting of three sections, the book delves into recent biocomputing and bioinformatics protocols, state-of-the art modern biophysical, electrophoretic, and chromatographic methods and high-throughput screening approaches, as well as detailed protocols and examples of the inhibition analysis and evaluation of selected enzymes. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, Targeting Enzymes for Pharmaceutical Development: Methods and Protocols serves as a vital reference for academics and industry professionals working on expanding our understanding of the wide range of important enzyme targets. The chapter "Enzyme-Ligand Interaction Monitored by Synchrotron Radiation Circular Dichroism" is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical technology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Enzymology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicinal chemistry</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Labrou, Nikolaos</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)1196634866</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781071601624</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781071601648</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781071601655</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-0716-0163-1</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-PRO</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-PRO_2020_Fremddaten</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032991935</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-0716-0163-1</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-0716-0163-1</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV047606951 |
illustrated | Not Illustrated |
index_date | 2024-07-03T18:38:40Z |
indexdate | 2024-07-10T09:16:02Z |
institution | BVB |
isbn | 9781071601631 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032991935 |
oclc_num | 1286867725 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
owner_facet | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
physical | 1 Online-Ressource (XI, 290 Seiten) Illustrationen |
psigel | ZDB-2-PRO ZDB-2-PRO_2020_Fremddaten |
publishDate | 2020 |
publishDateSearch | 2020 |
publishDateSort | 2020 |
publisher | Springer US |
record_format | marc |
series2 | Methods in Molecular Biology |
spelling | Targeting Enzymes for Pharmaceutical Development Methods and Protocols edited by Nikolaos E. Labrou 1st ed. 2020 New York, NY Springer US 2020 1 Online-Ressource (XI, 290 Seiten) Illustrationen txt rdacontent c rdamedia cr rdacarrier Methods in Molecular Biology 2089 In Silico Laboratory: Tools for Similarity-Based Drug Discovery -- The In Silico Fischer Lock-and-Key Model: The Combined Use of Molecular Descriptors and Docking Poses for the Repurposing of Old Drugs -- Determination of Half-Maximal Inhibitory Concentration of an Enzyme Inhibitor -- Applications of Differential Scanning Fluorometry and Related Technologies in Characterization of Protein-Ligand Interactions -- High-Throughput Differential Scanning Fluorimetry of GFP-Tagged Proteins -- Enzyme-Ligand Interaction Monitored by Synchrotron Radiation Circular Dichroism -- Measuring Small Molecule Binding to Escherichia coli AcrB by Surface Plasmon Resonance -- Systematic Screening of Viral Entry Inhibitors Using Surface Plasmon Resonance -- Screening of Beta-Secretase Inhibitors by Capillary Electrophoresis-Mass Spectrometry -- Electrophoretic Mobility Shift Assays with GFP-Tagged Proteins (GFP-EMSA) -- On-Line Enantioselective Capillary Electrophoretic Method for Screening Cytochrome P450 3A4 Inhibitors -- Enzymatic Bioautographic Methods -- High-Throughput Assessment of Metabolism-Induced Toxicity of Compounds on a 384-Pillar Plate -- Droplet-Based Microfluidics Methods for Detecting Enzyme Inhibitors -- Ligand Fishing: An Approach for the Discovery Inhibitors from Complex Biological Mixtures -- HMG-CoA Reductase as Target for Drug Development -- Lipoxygenases as Targets for Drug Development -- Cholinesterase as a Target for Drug Development in Alzheimer's Disease This volume explores detailed methods and experimental protocols evaluating the effect of a compound or a mixture of compounds on the action of enzymes that are significant targets in pharmaceuticals. Consisting of three sections, the book delves into recent biocomputing and bioinformatics protocols, state-of-the art modern biophysical, electrophoretic, and chromatographic methods and high-throughput screening approaches, as well as detailed protocols and examples of the inhibition analysis and evaluation of selected enzymes. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, Targeting Enzymes for Pharmaceutical Development: Methods and Protocols serves as a vital reference for academics and industry professionals working on expanding our understanding of the wide range of important enzyme targets. The chapter "Enzyme-Ligand Interaction Monitored by Synchrotron Radiation Circular Dichroism" is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com Pharmaceutical technology Enzymology Medicinal chemistry Labrou, Nikolaos Sonstige (DE-588)1196634866 oth Erscheint auch als Druck-Ausgabe 9781071601624 Erscheint auch als Druck-Ausgabe 9781071601648 Erscheint auch als Druck-Ausgabe 9781071601655 https://doi.org/10.1007/978-1-0716-0163-1 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Targeting Enzymes for Pharmaceutical Development Methods and Protocols Pharmaceutical technology Enzymology Medicinal chemistry |
title | Targeting Enzymes for Pharmaceutical Development Methods and Protocols |
title_auth | Targeting Enzymes for Pharmaceutical Development Methods and Protocols |
title_exact_search | Targeting Enzymes for Pharmaceutical Development Methods and Protocols |
title_exact_search_txtP | Targeting Enzymes for Pharmaceutical Development Methods and Protocols |
title_full | Targeting Enzymes for Pharmaceutical Development Methods and Protocols edited by Nikolaos E. Labrou |
title_fullStr | Targeting Enzymes for Pharmaceutical Development Methods and Protocols edited by Nikolaos E. Labrou |
title_full_unstemmed | Targeting Enzymes for Pharmaceutical Development Methods and Protocols edited by Nikolaos E. Labrou |
title_short | Targeting Enzymes for Pharmaceutical Development |
title_sort | targeting enzymes for pharmaceutical development methods and protocols |
title_sub | Methods and Protocols |
topic | Pharmaceutical technology Enzymology Medicinal chemistry |
topic_facet | Pharmaceutical technology Enzymology Medicinal chemistry |
url | https://doi.org/10.1007/978-1-0716-0163-1 |
work_keys_str_mv | AT labrounikolaos targetingenzymesforpharmaceuticaldevelopmentmethodsandprotocols |